KPV Dosage Calculator
KPV dosage calculator math is all we can offer, because we found no human dosing study of KPV. We searched PubMed and ClinicalTrials.gov on 16 November 2026 and found no trial that gave KPV to people, so we could not trace any figure posted online to human research. The KPV papers we read worked in mice, rats, donated skin and cells in a dish, using routes such as drinking water, gels and microneedles, and none of their abstracts described a shot under the skin.
This page gives you the math and the evidence map. Bring a figure and the calculator works out the strength, the liquid volume and the line to read on a U-100 barrel. Below it are units grids for 10 mg and 5 mg vials, a table of every KPV study we read with its species and route, and a route map that shows how far that research sits from a syringe.
Set the vial, the water and a figure
Results stay hidden until you enter a figure. We found no human clinical dose for KPV, so the tool starts at zero and leaves the number to you.
Drag or type. Every box below updates at once.
On this page
How many units is KPV in a 10 mg or 5 mg vial?
In the math for a 10 mg vial with 2 mL of water, 500 mcg sits at the 10 unit line and 1 mg at the 20 unit line. Each grid below has one row per sample figure and one column per water volume. The 250 mcg, 500 mcg and 1 mg rows are just easy numbers for showing the division. We did not take them from any study, and they are not advice.
| Figure | 1 mL water (10 mg/mL) | 2 mL water (5 mg/mL) | 3 mL water (3.33 mg/mL) |
|---|---|---|---|
| 250 mcg | 2.5 units | 5 units | 7.5 units |
| 500 mcg | 5 units | 10 units | 15 units |
| 1 mg | 10 units | 20 units | 30 units |
| Figure | 1 mL water (5 mg/mL) | 2 mL water (2.5 mg/mL) | 3 mL water (1.67 mg/mL) |
|---|---|---|---|
| 250 mcg | 5 units | 10 units | 15 units |
| 500 mcg | 10 units | 20 units | 30 units |
| 1 mg | 20 units | 40 units | 60 units |
One line of math gives every cell: units equal the figure in mcg, times the water in mL, divided by the vial in mcg, times 100. Check one: 1,000 mcg times 3 mL is 3,000, divided by 5,000 mcg is 0.6 mL, which is 60 units in a 5 mg vial. A 10 mg vial always needs half the units of a 5 mg vial at the same water.
Sources: arithmetic only, no outside figures.
What has KPV research actually tested?
The studies below are the KPV papers we read on PubMed today. Each row names the animal or cell type and how KPV reached it. Where the abstract leaves out the amount, we say so rather than guess. No row is a human trial.
| Model | Species | Route | Amount in the abstract | Looked at | Ref |
|---|---|---|---|---|---|
| colitis (DSS and TNBS) | mouse | by mouth, mixed into drinking water | not stated | gut tissue damage, inflammation signals | [1] |
| gut lining and T cells in a dish | human cell lines | added to the dish | nanomolar strengths | NF-kappaB and cytokine signals | [1] |
| colitis (DSS and T cell transfer) | mouse, including mice with a broken MC1 receptor | not named in the abstract | not stated | weight regain, gut tissue, MPO enzyme, survival | [2] |
| crystal and IL-1beta peritonitis | mouse | systemic (body wide) | not stated | build up of one type of white blood cell (polymorphonuclear leukocytes) in the belly cavity | [3] |
| ulcerative colitis | mouse | by mouth, packed in nanoparticles inside a gel | not stated | gut lining damage, TNF-alpha | [4] |
| TNBS colitis | rat | into the rectum, in a gel | not stated | weight, disease score, colon length | [5] |
| mouth sores after chemotherapy | rat | gel on the gums | not stated | food intake, gum healing, cytokines | [6] |
| skin cells in a dish | human cell lines and normal human skin cells | added to the dish | 10 to the power of minus 15 up to 10 to the power of minus 7 molar | calcium and cyclic AMP signals | [7] |
| airway lining cells in a dish | human cell line | added to the dish | a range, effect grew with amount | NF-kappaB, IL-8, eotaxin | [8] |
| skin permeation in the lab | donated human skin, not a living person | on the skin: passive, microneedles, iontophoresis (a small electric current), and microneedles plus iontophoresis | passive: below 0.01 microgram/mL; microneedles: 4.4 microgram/cm2 per hour; iontophoresis 8 times and the two together 35 times the microneedle rate | how much crossed the skin | [9] |
A result in a mouse gut or a dish of cells does not tell you what happens in a person. These papers show where scientists have looked, not what KPV does for anyone.
Disclaimer: the strengths and skin rates in this table are lab and animal measurements, not a dose for anyone. Read them as research notes, never as medical advice.
Sources: refs [1] to [9] below (PMIDs 18061177, 18092346, 12750433, 28143741, 34547895, 34846053, 15102092, 22837805, 28343991), all pulled from PubMed the same day, 16 November 2026.
How far is KPV research from a syringe?
Online calculators, this one included, assume a shot under the skin. The research did something else. This map lines up each route the abstracts describe:
| Route | Tested in | Refs |
|---|---|---|
| By mouth (water or nanoparticles) | mice | [1] [4] |
| Gel in the rectum or on the gums | rats | [5] [6] |
| Body wide, route not named | mice | [3] |
| Through skin with microneedles, a small electric current (iontophoresis), or both | donated human skin in the lab | [9] |
| In a dish | human cell lines | [1] [7] [8] |
| Shot under the skin | not found in any abstract we read | none |
The skin study is a good example of why route matters. With no help, KPV crossed donated skin below the lab test limit of 0.01 microgram per mL. Microneedles raised it to 4.4 microgram per square cm per hour. A small electric current (iontophoresis) raised the rate 8 times above microneedles alone, and the two together 35 times. The same peptide moved very differently depending on how it was applied.
Sources: refs [1], [3] to [9] in the Sources list below.
Has anyone tested KPV in people?
Not that we could find. Our PubMed search for KPV or Lys-Pro-Val tagged as a clinical trial or randomised trial gave 0 results. A wider PubMed search for KPV or Lys-Pro-Val in the title or abstract, tagged as human research, with dose, dosing, patients or volunteers in the title or abstract or tagged as a clinical trial, gave 14 papers, and none of them gave KPV to a person. ClinicalTrials.gov had 0 entries for KPV or Lys-Pro-Val. In the US, DailyMed lists 0 KPV labels and the openFDA approvals data has no match. Other national registers were not searched.
KPV is tiny. PubChem gives it a molar mass of 342.43 g/mol, so 1 mg holds about 2,920 nmol (0.001 divided by 342.43, times one billion). The cell studies reported effects at nanomolar strengths, but that still says nothing about a human amount.
Sources: refs [10] to [12] in the Sources list below, all searched on 16 November 2026.
How do I choose the water for a KPV vial?
The water sets the strength, not the amount of KPV. With 1 mL a 10 mg vial is 10 mg per mL and small figures sit near the first lines. With 3 mL it is about 3.33 mg per mL and the lines spread out, but big figures may not fit a 30 unit syringe. The general peptide reconstitution calculator does the same math for other peptides, and our guide on how to use peptides covers reconstitution and storage.
Where do I read about KPV and the KLOW blend?
For what KPV is and its research background, see the KPV peptide profile. KPV is one of four peptides in KLOW, with BPC-157, TB-500 and GHK-Cu, as our KLOW protocol page sets out, and the KLOW peptide dosage chart covers the blend math.
Sources
1. Dalmasso G, Charrier-Hisamuddin L, Nguyen HT, Yan Y, Sitaraman S, Merlin D. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology. 2008;134(1):166-78. PMID: 18061177. DOI: 10.1053/j.gastro.2007.10.026.
2. Kannengiesser K, Maaser C, Heidemann J, et al. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease. Inflamm Bowel Dis. 2008;14(3):324-31. PMID: 18092346. DOI: 10.1002/ibd.20334.
3. Getting SJ, Schioth HB, Perretti M. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptides. J Pharmacol Exp Ther. 2003;306(2):631-7. PMID: 12750433. DOI: 10.1124/jpet.103.051623.
4. Xiao B, Xu Z, Viennois E, et al. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative Colitis. Mol Ther. 2017;25(7):1628-1640. PMID: 28143741. DOI: 10.1016/j.ymthe.2016.11.020.
5. Sun J, Xue P, Liu J, et al. Self-Cross-Linked Hydrogel of Cysteamine-Grafted gamma-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in Rats. ACS Biomater Sci Eng. 2021;7(10):4859-4869. PMID: 34547895. DOI: 10.1021/acsbiomaterials.1c00792.
6. Shao W, Chen R, Lin G, et al. In situ mucoadhesive hydrogel capturing tripeptide KPV: the anti-inflammatory, antibacterial and repairing effect on chemotherapy-induced oral mucositis. Biomater Sci. 2021;10(1):227-242. PMID: 34846053. DOI: 10.1039/d1bm01466h.
7. Elliott RJ, Szabo M, Wagner MJ, Kemp EH, MacNeil S, Haycock JW. alpha-Melanocyte-stimulating hormone, MSH 11-13 KPV and adrenocorticotropic hormone signalling in human keratinocyte cells. J Invest Dermatol. 2004;122(4):1010-9. PMID: 15102092. DOI: 10.1111/j.0022-202X.2004.22404.x.
8. Land SC. Inhibition of cellular and systemic inflammation cues in human bronchial epithelial cells by melanocortin-related peptides: mechanism of KPV action and a role for MC3R agonists. Int J Physiol Pathophysiol Pharmacol. 2012;4(2):59-73. PMID: 22837805.
9. Pawar K, Kolli CS, Rangari VK, Babu RJ. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human Skin. J Pharm Sci. 2017;106(7):1814-1820. PMID: 28343991. DOI: 10.1016/j.xphs.2017.03.017.
10. PubMed searches run 16 November 2026: (KPV[tiab] OR Lys-Pro-Val[tiab]) AND humans[mh] AND (clinical trial[pt] OR dose[tiab] OR dosing[tiab] OR volunteers[tiab] OR patients[tiab]), 14 results, none a study that gave KPV to people; (KPV[tiab] OR Lys-Pro-Val[tiab]) AND (clinical trial[pt] OR randomized controlled trial[pt]), 0 results. ClinicalTrials.gov searches for KPV as an intervention and for Lys-Pro-Val, 0 studies.
11. PubChem. Msh (11-13), Lys-Pro-Val, CID 125672, formula C16H30N4O4, molecular weight 342.43 g/mol. pubchem.ncbi.nlm.nih.gov, read 16 November 2026.
12. DailyMed (dailymed.nlm.nih.gov) drug name search for KPV, 0 labels; openFDA Drugs@FDA (api.fda.gov) query for lysylprolylvaline as an ingredient returned nothing. Run on 16 November 2026; these cover US records and no other country.
Use, share or cite this calculator
Embed it on your site, copy a citation, or add Peptides Vietnam as a preferred source on Google.
Frequently asked questions
What is the KPV dosage for people?
There is none from research. On 16 November 2026 we searched PubMed for KPV or Lys-Pro-Val in human clinical trials and found 0, and a wider human search turned up 14 papers, none of which gave KPV to a person. ClinicalTrials.gov listed 0 KPV studies. We could not trace any amount posted online to a human trial.
Was KPV taken by mouth or injected in research?
In the animal studies we read, KPV went in by mouth in drinking water or nanoparticles, into the rectum in a gel, or onto the gums in a gel. One mouse study says only that it was given body wide. None of the abstracts we read describes a shot under the skin, which is the route this syringe math assumes.
How many units is 500 mcg of KPV from a 10 mg vial?
At 2 mL of water, the vial works out to 5 mg in each mL, so 500 mcg takes 0.1 mL, the 10 unit line on a U-100 barrel. Mixed with 1 mL instead, the line drops to 5; mixed with 3 mL, it rises to 15. The 500 mcg figure is only an example for the arithmetic.
Does a 5 mg KPV vial change the math?
Yes. Half the peptide in the same water means half the strength, so any amount needs twice the units. With 2 mL, 500 mcg is 10 units from a 10 mg vial and 20 units from a 5 mg vial.
Is KPV an approved medicine?
We found no US approval. DailyMed returned 0 KPV labels and the openFDA approvals data returned no match on 16 November 2026. Other national registers were not searched.
Is KPV the same as alpha-MSH?
No. KPV is the last three building blocks (lysine, proline, valine) of the hormone alpha-MSH. In a 2003 mouse study of peritonitis, KPV cut the build up of one type of white blood cell (polymorphonuclear leukocytes) but behaved differently from the core alpha-MSH pieces, and its authors judged it unlikely to work through melanocortin receptors.
Is KPV in the KLOW blend?
Yes, KPV is one of the four peptides in KLOW. The blend has its own pages, so this calculator covers KPV on its own. See the KLOW dosage chart for blend math.
Does this tool pick a KPV amount for me?
No. With no human study to lean on, it has nothing to pick from. It starts empty, and once you type a figure it shows the strength, the mL and the syringe mark.
Math and research notes only
Nothing here is medical advice. The calculator divides numbers you enter, and the research tables describe animals and cells, not people.